Loading
The US defense department's pancreatic cancer research fund, created by Congress in 2020. It funds work towards prevention, earlier diagnosis and new treatments, and has made about 100 awards.
Congress established the Pancreatic Cancer Research Program in the FY20 Department of Defense appropriation with $6 million; the CDMRP had funded pancreatic cancer research through the Peer Reviewed Cancer Research Program since 2011. Its mission is to promote rigorous, innovative, high-impact pancreatic cancer research that leads to prevention, earlier diagnosis, new therapeutic tools and improved outcomes. The page notes there is no screening test for the disease and that it is often found after it has spread.
The page lists congressional appropriations of $66 million for FY20 to FY24 and $20 million for FY26, and 102 awards in FY20 to FY24.
Shares Congressionally Directed Medical Research Programs (CDMRP), The hardest cancers are found late and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP), Peer Reviewed Cancer Research Program (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP), The hardest cancers are found late and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Congressionally Directed Medical Research Programs (CDMRP) and the tag research-funding.
Shares Pancreatic ductal adenocarcinoma and the tag research-funding.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/